JPRN-jRCTs061210078招募中2 期
Single-center, open-label, single-arm clinical study to confirm the efficacy and safety of topical delgocitinib ointment in patients with rosacea and rosacea-like dermatitis
Kajita Ai0 个研究点目标入组 30 人开始时间: 2022年2月22日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1)Patients aged 20 years or over at the time of agreement
- •2)Patient who have agreed by their own decision, with the written consent form, following the appropriate procedure of informed- consent.
- •3)Patient diagnosed as rosacea or rosacea-like dermatitis.
- •4)Patient that with refractory rosacea or rosacea-like dermatitis despite the standard treatments for 12 weeks or more
- •5)Patient without a history of delgocitinib ointment therapy
排除标准
- •1)Patient who have previously been treated with delgocitinib ointment.
- •2)Patients with any of the following disease to be differentiated: seborrheic dermatitis, atopic dermatitis (rosacea-like dermatitis arising in a patient with atopic dermatitis is not excluded), contact dermatitis, acne vulgaris, dermatomyositis, lupus erythematosus, drug eruption, lupus miliaris disseminatus faciei, eosinophilic pustular folliculitis, dermatomycosis and photo-allergy.
- •3)Miscellaneous: Patient who are considered ineligible for enrolling the study by a principal investigator or co-investigators.
研究者
相似试验
进行中（未招募）
1 期
Clinical study to evaluate the handling and safety of AVT06 PFS in subjects with chorioretinal vascular disease (ALVOEYE-D).chorioretinal vascular disease (neovascular age-related macular degeneration [nAMD], diabetic macular edema [DME], myopic choroidal neovascularization [CNV], retinal vein occlusion [RVO] and diabetic retinopathy [DR])MedDRA version: 20.1Level: PTClassification code: 10012689Term: Diabetic retinopathy Class: 100000004853MedDRA version: 20.0Level: PTClassification code: 10071129Term: Neovascular age-related macular degeneration Class: 100000004853MedDRA version: 20.0Level: PTClassification code: 10038907Term: Retinal vein occlusion Class: 100000004853MedDRA version: 20.1Level: LLTClassification code: 10057934Term: Diabetic macular edema Class: 10015919MedDRA version: 21.1Level: LLTClassification code: 10073711Term: Myopic choroidal neovascularization Class: 10015919CTIS2023-505225-13-00Alvotech Swiss AG35
进行中（未招募）
不适用
Clinical trial to evaluate the efficacy and safety of SRT(Selective Retina Therapy) in patients with Diabetic Macular EdemaDiseases of the eye and adnexaKCT0001415The Catholic University of Korea, Yeouido St. Mary's Hospital23
招募中
1 期
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency.patients with cystic fibrosis suffering from pancreatic exocrine insufficiencyMedDRA version: 21.0Level: PTClassification code: 10079428Term: Cystic fibrosis gastrointestinal disease Class: 100000004850CTIS2023-503256-27-00MEDA Pharma GmbH & Co. KG80
进行中（未招募）
不适用
To study the effect of Ischemia Reversal Program (IRP) along with diet modification for subjects suffering Coronary Artery Disease (CAD).CTRI/2020/01/022814Vaidya Sane Ayurvedic Lab Pvt Ltd
已完成
4 期
To Evaluate The Efficacy And Safety Of Nimulid Strong Gel in Subject suffering From Pain Associated With Recent Muscle or Joint Injuries.CTRI/2022/11/047591Mankind Pharma Limited60